CD79A and rheumatoid arthritis: As shown in Figure 5C, the levels of antibodies against HSP60 in ACPA+ RA patients were significantly increased for IgA antibodies, with only a trend for IgG and IgM anti-HSP60 antibodies for both serum and SF samples.